Ivonescimab (PD-1/VEGF) Received Priority Review from China’s NMPA for First-Line Treatment of PD-L1 Positive NSCLC
The Second Indication of Ivonescimab in NSCLC2L+ EGFRm NSCLC Already Approved in May 2024 HONG...
Blog
Baldwin Insurance director sells shares worth over $827,000
In recent trading activity, Baldwin Insurance Group, Inc. (NASDAQ:BWIN) director Baldwin Lowry, who is also...
reAlpha Tech Corp. Announces Financial Results for the Quarter Ended June 30, 2024
Dublin, Ohio–(Newsfile Corp. – August 14, 2024) – reAlpha Tech Corp. (NASDAQ: AIRE) (“reAlpha,” the...
Cisco sees recovery in equipment demand, cuts 7% jobs globally
By Juby Babu (Reuters) – Cisco Systems said on Wednesday it was witnessing rebounding demand...
Kimbell Royalty Partners controller sells $78,550 in company stock
Kimbell Royalty Partners, LP (NYSE:) reported that its Controller, Rhynsburger Blayne, sold 5,000 common units...
Warren Buffett details Berkshire’s Apple, Chevron and Capital One sales while also buying more Chubb
OMAHA, Neb. (AP) — Warren Buffett offered more details Wednesday about the stocks he has...
Dividend Investor Who Earns $4000 Per Month Shares His Top 7 Portfolio Holdings
Dividend Investor Who Earns $4000 Per Month Shares His Top 7 Portfolio Holdings Benzinga and...
Fed rate cut looms—a September slash is expected, but the size of the cut is unknown
The latest consumer price report “checked the box” for the Fed to start cutting rates in September, according to TD Securities’ strategists led by Oscar Munoz and Gennadiy Goldberg.
